Genesys Announces First Half Fiscal Year 2022 Cloud Business Growth

Genesys®, a global cloud leader in customer experience orchestration, announced results for the company’s first six…

Klarna hits record 20 million US customers as demand for flexible payment options soars

 Klarna, the leading global retail bank, payments and shopping service, today announced it has doubled its…

Hanwha Solutions wins $260-million supply contract for high-pressure tanks in U.S.

 Hanwha Solutions announced that its newly acquired tank manufacturer Hanwha Cimarron signed a deal with Texas-based energy…

Puhui Wealth Investment Management Co., Ltd. Announces Closing of $2,750,000 Registered Offering of Debenture

Puhui Wealth Investment Management Co., Ltd. (Nasdaq: PHCF) (“Puhui” or the “Company”), a third-party wealth management service…

Nvidia’s US$40 billion deal for ARM dealt blow

Jensen Huang (Nvidia) IN THE SPOTLIGHT Australian ransomware breaches jump 24%TPG Telecom weighing potential sale of…

New funding round could put Databricks’ value at US$3b

Databricks, the red-hot data analytics and data lake platform developer, is putting together a new round…

City Office REIT Announces Agreements to Sell Life Science Portfolio for $576 Million

City Office REIT, Inc. (NYSE: CIO) (“City Office” or the “Company”) announced today that it has entered…

Bit Digital, Inc. Announces Second Quarter of Fiscal Year 2021 Financial Results

Bit Digital, Inc. (Nasdaq: BTBT) (the “Company”), a bitcoin mining company headquartered in New York, today announced its…

Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and…

Calliditas Therapeutics has resolved on a directed share issue in the amount of 2.4 million shares, raising proceeds of approximately SEK 324 million

 Calliditas Therapeutics AB (publ) (“Calliditas” or the “Company”) (Nasdaq Stockholm: CALTX) (Nasdaq: CALT), a biopharma company focused on identifying,…